Table 3 Cancer classes, their abbreviations, and number of anticancer drugs
From: A systematic analysis of FDA-approved anticancer drugs
Cancer | Abbreviation | Number of drugs | Number of targeted drugs | Number of cytotoxic drugs |
|---|---|---|---|---|
Leukemia | Leukemia | 40 | 16 | 24 |
Lymphoma | Lymphoma | 28 | 14 | 14 |
Breast cancer | BRCA | 27 | 14 | 13 |
Lung cancer | Lung cancer | 17 | 7 | 10 |
Prostate cancer | PCa | 15 | 12 | 3 |
Ovarian cancer | OV | 12 | 2 | 10 |
Melanoma | Melanoma | 11 | 10 | 1 |
Colorectal cancer | CRC | 10 | 5 | 5 |
Kidney cancer | KNC | 10 | 8 | 2 |
Stomach cancer | GCA | 10 | 5 | 5 |
Brain cancer | BrainC | 8 | 2 | 6 |
Multiple myeloma | MM | 8 | 5 | 3 |
Pancreatic cancer | PACA | 8 | 3 | 5 |
Testicular cancer | TC | 6 | 0 | 6 |
Head and neck cancer | HNC | 5 | 2 | 3 |
Sarcoma | Sarcoma | 5 | 2 | 3 |
Bladder cancer | BCA | 4 | 0 | 4 |
Thyroid cancer | THC | 4 | 3 | 1 |
Bone cancer | BoneC | 3 | 1 | 2 |
Basal cell carcinoma | BCC | 2 | 2 | 0 |
Cervical cancer | CC | 2 | 0 | 2 |
Gestational trophoblastic disease | GTD | 2 | 0 | 2 |
Adrenal cortical carcinoma | ACR | 1 | 0 | 1 |
Choriocarcinoma | CCA | 1 | 0 | 1 |
Esophageal cancer | EC | 1 | 1 | 0 |
Gastroenteropancreatic neuroendocrine tumor | GEP-NET | 1 | 1 | 0 |
Kaposi’s sarcoma | KS | 1 | 1 | 0 |
Liver cancer | Liver cancer | 1 | 1 | 0 |
Mesothelioma | Mesothelioma | 1 | 0 | 1 |
Myelofibrosis | MF | 1 | 1 | 0 |
Penile cancer | PC | 1 | 0 | 1 |
Retinoblastoma | RB | 1 | 0 | 1 |
Vulvar cancer | VUC | 1 | 0 | 1 |